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Abstract
It has been reported that muscles of myoD / mice present a lower potential to regenerate, but there are no reports on the effect of
acute interference with myoD expression limited in space and time to only a particular regenerating muscle. Here we relied on antisense
inhibition of this factor. Four different oligos were tested. The suppression of regeneration indices (the expression of desmin, the formation of
myotubes and the initiation of endplates) was the most pronounced, with the oligomer targeting a region encompassing the translation start
site of myoD. A mixed backbone phosphorothioate–phosphate diester oligo (200 Al at 20 AM) was still detectable in the muscles 1 h after its
administration and reverse transcription-polymerase chain reaction (RT-PCR) analysis showed that the level of the targeted 5V end of the
myoD mRNA was selectively decreased. The level of myoD protein was also lowered. Four hours after the antisense treatment, when the
oligos were no longer detectable, the myoD mRNA level was restored and 24 h later it exceeded controls together with that of myf-5 and
myogenin. After 4 weeks, the antisense-treated soleus muscles were similar to the control-treated and the untreated regenerated soleus with
respect to fiber types and motor endplates, however, they contained smaller fibers which reflected the asynchronity of regeneration. This
shows that successfully targeted simple antisense oligonucleotides can be used as selective tools for inhibition of individual factors in
studying the process of muscle regeneration. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
It has been suggested that muscle regeneration is con-
trolled by myoD, a nuclear protein, member of the group of
myogenic regulatory factors (MRF: myoD, myf-5, myoge-
nin, MRF4, reviewed by Ref. [1]). The myoD knock-out
mice upregulate myf-5 [2], but otherwise are grossly normal,
however their muscles contain increased levels of morpho-
logically normal satellite cells and in spite of this, they show
a lower potential to regenerate compared to the wild type [3].
The decreased regeneration potential is documented by a
number of independent experiments on myoD null mice both
in vitro and in vivo. First, primary cultures of myoD /
myogenic cells showed a clear differentiation deficit com-
pared to the wild type. Thus, these myogenic cells were
considered as representing an intermediate stage between
quiescent satellite cells and myogenic precursor cells [4,5].
In line with these observations, also satellite cells obtained
from single muscle fiber cultures of myoD(/) mice were
found to be more reluctant to differentiate, to show molecular
and cellular characteristics different from those of the wild
type and to present an altered expression pattern of the other
MRF genes [6]. Classical in vivo regeneration models, like
regeneration following crushing of muscle [3] or grafting
muscle into another location [7] also indicated a delayed
regeneration in myoD(/) mice. All these data strongly
corroborate to the view that myoD is important for proper
muscle regeneration. However, it should be stressed that
muscles of myoD(/) mice do not express this regulatory
factor and have never expressed it during their development.
Therefore, their muscles differ from the wild type. This may
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critically affect the background determining the conditions
of muscle regeneration [3–7]. Hence, experiments in which
inhibition of myoD expression is limited in place and time to
a particular muscle entering the initial phase of regeneration
could provide further information on the role of this factor.
According to our knowledge, such an experiment has not
been performed yet.
Antisense nucleic acids are potential useful tools to
provoke such a spatio-temporal inhibition of gene expression
[8], and they can be easily introduced both into myoblasts
and myotubes [9,10]. Here, we injected antisense oligonu-
cleotides in soleus muscles which were regenerating from
notexin-induced necrosis [11]. This regeneration model has
been extensively characterised both in our laboratories
[12–15] and by others [16,17] and found to be remarkably
reproducible. We injected antisense oligomers targeted to
different parts of the myoD mRNA 3 days after the induction
of necrosis—i.e. at the time when the mRNA level for this
transcription factor was at its maximum in regenerating
muscle. The results show that injection of oligos targeted
to a sequence encompassing the translational start site
temporarily blocked muscle regeneration. The transcript
and protein levels of myoD were initially suppressed but
shortly thereafter rebounded and increased above control.
The augmentation of myoD mRNA level was accompanied
by similar increases in the levels of the myf-5 and myogenin
transcripts confirming that in vivo the expression of these
factors is closely regulated. Thereby, oligo injection dis-
turbed the synchronization of the early steps of regeneration,
delaying the expression of desmin, the formation of myo-
tubes and the reinnervation of the fibers. After 4 weeks of
regeneration, similar proportions of the fibers expressed the
different MyHC isoforms in antisense-treated muscles as in
the controls or in the untreated regenerated muscles, but the
antisense-treated muscles showed increased numbers of
small fibers, a sign of asynchronous regeneration [18].
2. Materials and methods
2.1. Selection and synthesis of oligodeoxynucleotides
Oligonucleotides containing naturally occurring phos-
phodiester bonds are subject to quick nucleolytic decom-
position in cells. In order to stabilize our molecules,
phosphorothioate internucleotide linkages were incorpo-
rated in a sequence-specific manner according to the prin-
ciple of minimal modification [19]. Two thioate substituents
were built in, on both the 5V and the 3V terminus, and one
was positioned in the vicinity of each pyrimidine nucleotide,
on either the 5V or the 3V side. The selection of target sites
for antisense oligonucleotides was based on functional and
structural considerations. We chose first the transcriptional
start site as one of the potentially most vulnerable positions
as shown by statistical evaluations [20]. Further candidate
target sites were selected based on a prediction of the most
probable secondary structures of the myoD mRNA com-
puted by free energy minimization. For this purpose, the
computer software mfold (version 3.0) of Zuker and Turner
was applied [21]. Single-stranded regions were selected as
potential target sites. The chosen fragments were further
screened on the basis of the general criteria of primer
planning and the free energy of duplex formation.
Oligodeoxynucleotides were synthesized on an Expedite
8909 synthesizer (Perkin-Elmer Biosystems, USA) on a
scale of 1 Amol by the solid-supported h-cyanoethyl phos-
phoramidite method. Phosphorothioate linkages were built
in at given positions by substituting the iodine oxidation
with 0.4 M dibenzoyl tetrasulfide treatment for 2 min in the
standard protocol. [22]. Production, purification, purity
control and the measurement of the degree of thioation
were performed as described elsewhere [23]. Purity of the
products was > 97%, the phosphorothioate/phosphodiester
ratio corresponded to the expected theoretical ratio of
phosphorothioate and phosphodiester groups within the
experimental error. The sequences of the oligos are shown
in Table 1.
2.2. Animal treatment, administration of notexin and the
antisense oligomers
Muscle injury was induced by the in situ injection of
notexin, a snake venom [11]. The optimal notexin dose for
inducing muscle necrosis had been established previously
and the ensuing regeneration process in the soleus muscle
was found to be remarkably reproducible as assessed by
histological inspection and by a number of biochemical
criteria [12–15]. Notexin was administered as described
previously [12]. Shortly, male 300–360 g Wistar rats were
narcotised by intraperitoneal injection of 1 ml 0.5% Na-
pentobarbital per 100 g body weight. An incision was made
through the skin on the lateral side of the left hind leg, the m.
gastrocnemius was gently pulled aside and the soleus was
slightly lifted up from its bed. Twenty micrograms of notexin
in 200 Al of 0.9% NaCl was injected into the soleus. Finally,
the wound in the skin was suture closed. On the third day
after the injection of the toxin, the wound was opened again,
and various concentrations of antisense DNA oligomers or
adequate controls dissolved in 200 Al of 0.9% NaCl were
injected into the regenerating muscle. At 1, 4, 24, 48 h or 25
days after oligo injection, the soleus muscles were removed
Table 1
Sequence of oligomers used in the experiments
Name Sequence
Anti translational starta 5Vgtagctccatgtcccagttc3V
Anti cap site 5Vtgtcctggcccctagctta3V
Anti 245–264 5Vgccgtcggggcctagcaa3V
Random control 5Vtgaaggcgacgagaaggt3V
Scrambled antistart controlb 5Vtaccgtcgttcagatgctcc3V
a Used in both phosphorothioate and phosphate diester forms.
b Used only in phosphorothioate oligomer form.
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and the animals were sacrificed by an overdose of sodium
pentobarbital. Each time point combined data from at least
three animals, unless it is otherwise indicated. The earliest
time point (1 h after antisense injection) was chosen consid-
ering the high turnover rate of myoD mRNA in myogenic
cells [24]. The dissected muscles were tied onto a wooden
stick in an extended position, frozen in isopentane cooled by
liquid nitrogen and kept at  70 jC until use.
2.3. Reverse transcription-polymerase chain reaction (RT-
PCR)
The total RNA was isolated according to the method of
Ref. [25]. The total RNA content of muscles was not different
from those of the non-antisense-treated ones. The RT reaction
and the quantification by RT-PCR were done as described
earlier [12]. The primers and PCR conditions are shown in
Table 2. The number of PCR cycles was carefully adjusted to
the linear dynamic range of the test. The identity of the
amplified fragments of myoD, myf-5, myogenin, MRF4, Id1,
Id3, actin, SERCA1b and GAPDH was confirmed by sub-
cloning in pGEMTeasy (Promega, Leiden, Netherlands) and
sequencing. To radiolabel the PCR fragments for quantifica-
tion, 5 Al (i.e. one-tenth of the volume) of the primary PCR
mixture was transferred to a new tube and made up to 50 Al
with the same amplification mix, except that [a-32P] dCTP
was added. Two additional PCR cycles were executed with
Table 2
Primers and PCR conditions
Name Sequence Fragment
length (bp)
MyoD5V+ 5Vggttgagcgagaagcagga3V (nt 258–276a) 724
MyoD5V 5Vtgtagtaggcggcgtcgtag3V (nt 3710–3730a)
Id1 + 5Vcatgaaggtcgccagtagcag3V (nt 67–87b) 475
Id1 5Vgtccatctggttcttcctcagtgc3V (nt 521–544b)
Id3 + 5Vaaggcgctgagcccggtg3V (nt 18–35c) 387
Id3 5Vctgcgttcgggaggtgcc3V (nt 387–404c)
The temperature profile used for the PCR was 95, 60, 72 each for 1 min, for
myoD5V 28 cycles and for the Id1 and Id3 25 cycles were applied. The
other primers and PCR conditions for myoD, myf-5, myogenin, MRF4 and
a-actin have been described in Ref. [13] and for GAPDH and SERCA1b in
Ref. [12].
a Positions in the sequence of the rat myoD gene [26].
b Positions in the sequence of the rat Id1 cDNA [27].
c Positions in the sequence of the rat Id3 cDNA [28].
Fig. 1. The levels of markers of the progress of muscle regeneration. The levels of (A) myoD mRNA, (B) Id1 mRNA, (C) Id3 mRNA and (D) desmin in
regenerating soleus muscles. The indicated values for mRNA levels are normalized to the GAPDH mRNA level of the same sample. For the protein
immunoblots, extracts representing equal parts of the muscles (20–30 Ag proteins) were loaded onto each lane. The inserts show an example of the three
repetitions of the RT-PCR or the immunoblots. The vertical bars on columns representF S.E., N= 3, *P< 0.05, **P < 0.01 compared to the normal values.
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the same cycle parameters used in the primary PCR. The
amplification products were analyzed by electrophoresis on
6% polyacrylamide gels. The gels were airdried and 32P
bands quantified by means of a Storm model 840 Phosphor-
Imager (Molecular Dynamics, Sunnyvale, CA, USA).
2.4. Immunoblotting procedures
myoD Proteins were measured by immunoblotting as in
Ref. [29]. Muscles were homogenized in 31 volumes of
lysis buffer (HEPES 10 mM pH7.5, KCl 5 mM, MgCl2 10
mM, mercaptoethanol 5 mM, sucrose 0.32 M) supple-
mented with a protease-inhibitor cocktail (Sigma) at 4 jC,
vacuum-filtered through four layers of fine gauze and
subsequently centrifuged for 8 min at 1000 g resulting
in a supernatant fraction and a rough nuclear pellet. The
pellet was dissolved in a buffer containing HEPES 20 mM
pH 7.9, NaCl 0.42 M, EDTA 1 mM, DTT 2 mM glycerol
25% and subsequently used for gel electrophoresis and
Western blotting. For each muscle, 5% of the total nuclear
fraction or 0.25% of the total extract was loaded onto a 12%
Laemmli-type acrylamide gel. Electrophoresis and semi-dry
blotting onto PVDF membranes were carried out under
standard conditions. For immunodetection, we used a
1:250 dilution of the myoD1 antibody of Novocastra Labo-
ratories (Newcastle, UK), a 1:500 dilution of the myoD
rabbit antiserum of Santa Cruz Biotech. (Santa Cruz, CA,
USA) and a 1:300 dilution of the monoclonal desmin
antibody of Dako (Glostrup, Denmark). After incubation
with an HRP-coupled secondary antibody Dako (anti
mouse, 1:1000) a Ni-enhanced DAB/peroxidase reaction
was carried out [30] followed by densitometric quantifica-
tion. In some experiments, the immunoblots were evaluated
with the Vistra ECF system (Amersham Life Science, Little
Chalfont, England, UK) in which case alkaline phosphatase-
coupled secondary antibodies (1:10,000) were used and the
bands were quantified on the Storm FluorImager (Molecular
Dynamics, Sunnyvale, CA, USA).
2.5. 5-Bromo-2V-deoxyuridine (BrdU)-labelling and
detection
One milligram of BrdU in 200 Al 0.9% NaCl was injected
into the soleus in the same manner as the snake venom at
various days after the notexin treatment. Sixteen hours later,
the soleus was removed, fixed overnight at 4 jC in 4%
paraformaldehyde in PBS and kept at  20 jC until freeze
sectioning. Before making cross-sections, the soleus was cut
into six equally sized blocks from the proximal to the distal
tendon. Three sections from each block were randomly
chosen to be processed for immunostaining. To denature
the nuclear DNA, the sections were treated with 2 N HCl for
30 min and washed for 3 10 min in 50 mM Tris–HCl pH
7.6, 100 mM NaCl. The endogenous peroxydase was
quenched with 3% H2O2 in PBS for 5 min, followed by
2 10 min washes in PBS. Sections were blocked for 20 min
in 1% BSA and 5% normal goat serum. The primary anti-
body (mouse monoclonal anti-BrdU, Sigma, incubated for 1
h at 1:100) and the secondary antibody (biotinylated goat
anti-mouse, Vector Laboratories, incubated for 30 min at
1:300) were diluted with the blocking serum. For intermittent
washings, the blocking solvent was used after the primary
antibody and PBS after the secondary. The immunocom-
plexes were visualised by the Vectastain ABC Elite kit
(Vector Laboratories). The labelled nuclei were counted
under the light microscope. For background correction,
BrdU was also injected into control soleus muscles of
untreated animals and the average number of labelled nuclei
in three controls subtracted from the number of BrdU-
labelled nuclei of notexin-regenerated muscles.
2.6. Histochemistry and immunostainings
A 2-mm-thick block was taken from the central part of
each frozen soleus muscle and cryosections were stained
Fig. 2. The myoD level (A) and the incorporation of BrdU into the nuclei
(B) during regeneration of soleus muscles. (A) The myoD protein in the
first part of regeneration largely followed its transcript level (see Fig. 1A).
(B) The incorporation of BrdU reflects two mitotic waves in the first week
of regeneration. Note that the first mitotic wave on day 3 coincides with the
significant increase of myoD. These events mark the activation of myogenic
cells. N= 3. Symbols as in Fig. 1.
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with hematoxylin–eosin to monitor the extent of the
necrosis and the subsequent regeneration. Acetylcholines-
terase staining for motor endplates was done as in Ref. [13].
For immunostaining, cryosections were pretreated with
0.3% H2O2 and blocked in 10% rabbit serum, 1% BSA for
30 min. Primary antibodies for desmin (1:50 antibody,
Dako), for MyHC1 (BA-D5) or MyHC2a (SC-71) (1:10)
were used as in Refs. [14,29]. Immunoreactions were vi-
sualized with an HRP-coupled secondary antibody (1:150,
Dako) followed by a DAB/peroxidase reaction (0.05 mg/ml
DAB, 0.006% H2O2).
2.7. Measurement of the stability of oligodeoxynucleotides
in the muscle tissue
Phenol-chloroform washed total RNA extracts also con-
taining the oligonucleotides were prepared from the
oligomer-injected regenerating muscles and one-tenth of
the volume of these was subjected to 5V-end labelling with
[g-32P] ATP using T4 polynucleotide kinase as described by
Ref. [31]. The reaction mix was denatured at 65 jC for 5
min and loaded onto a 20% urea acrylamide gel. The dried
gel was subjected to phosphorimage analysis. The oligos
were identified by electrophoretic migration.
2.8. Fiber area and statistics
The fiber area was obtained by measuring light micro-
graphs of transversal muscle sections with a digitizer
interfaced to a computer. For each muscle, at least 100
fibers were measured.
To assess the significance of differences for the BrdU
incorporation, the Newman–Keuls test and for the RT-PCR,
the immunoblot and the fiber area, Student’s unpaired t-test
were used. P < 0.05 was considered as significant, P < 0.01
as very significant and P < 0.001 as extremely significant
level of difference.
3. Results
3.1. The changes in mRNA levels of myoD, ID1 and ID3 and
the level of desmin during normal muscle regeneration
The level of myoD mRNA, which is normally very low in
adult muscle, peaked on day 3 after administration of notexin
and declined gradually through the 4 weeks of regeneration
(Fig. 1A). We have also measured the transcript levels of the
helix–loop–helix transcriptional inhibitors of DNA binding
Fig. 3. The effect of phosphodiester oligonucleotides on the expression of desmin. Oligonucleotides were injected after the third day of regeneration and the
desmin level was measured after the fifth day. The different doses were tested in duplicate. The loadings were representing equal parts of the muscles also not
differing by protein content (20 Ag protein per lane). Symbols as in Fig. 1.
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Id1 and Id3 which are known to inhibit myogenic differ-
entiation [32,33]. Both Id1 and Id3 increased dramatically on
the first day and they also declined to the normal level by day
28 of regeneration (Fig. 1B,C). The level of desmin, a
differentiation marker for myoblasts, was low in the normal
soleus and it gradually increased to a maximum on days 5–
10, then decreased back to the normal level (Fig. 1D). We
reported earlier that desmin is expressed uniformally over the
whole transverse section from day 4 onward [13].
3.2. The myoD protein level and BrdU-labelling
The myoD protein level was low in the normal soleus,
but it began to rise already on the first day after notexin
injection and, similar to its transcript, became significantly
higher than the resting value on day 3 (Fig. 2A). Later in
regeneration, this factor remained well above the initial
resting value up till day 21 in spite of the fact that at this
time the myoD transcript was already clearly declining.
Fig. 4. The effect of anti start on muscle morphology during regeneration. The effect 2 days after injecting 2 10 5 M antistart phosphodiester oligo on (b) the
myotube formation, (d) the desmin expression and (f) the endplate formation into a soleus 3 days after notexin injection. Control slides of the myotubes, desmin
and endplates in muscles treated by the random oligomer are shown on (a), (c) and (e), respectively. The arrows point to (a) the myotubes, (c) the desmin-
positive myotubes and (d) myoblasts and the acetylcholinesterase stained endplates (e and f).
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In order to monitor cell proliferation, which sets in
immediately upon activation of satellite cells, we adminis-
tered BrdU, a thymidine analog, to the soleus (n = 3 for each
time point, results indicated F S.E.). The BrdU is incorpo-
rated into the DNA during the S phase of the cell cycle, and it
therefore labels nuclei involved in DNA replication. More
nuclei were labelled during the first 2 days following muscle
injury compared to the uninjured controls (423F 89 nuclei
labelled in untreated controls; 132F 66 extra nuclei on day 1
and 57F 55 on day 2 after notexin injection, Fig. 2B).
However, these differences were not statistically significant.
But after the third day, the increase became highly significant
(532F 71 above the controls, P < 0.01). This suggested that a
first wave of cell proliferation took place 3 days after notexin
administration. After 5 days, the incorporation was again not
significantly different from that of the control muscles. After
7 days, there appeared to be a second wave of mitosis
(453F 91 positive nuclei above the controls, P < 0.05).
3.3. myoD Antisense oligos inhibit the early steps of muscle
regeneration
Since the transcript levels of myoD, myf-5 and myogenin
show a maximum around the third day of regeneration in
soleus muscle (see above and in Ref. [13]), we chose this time
for the intramuscular administration of three different myoD
antisense oligos (phosphodiester oligos or phosphorothioate
oligos). In order to assess the impact of this treatment, we
monitored the maturation of the newly formed myotubes by
determining the expression of desmin, the increase in the
cytoplasm/nuclear volume ratio of the fibers, and the number
of endplates after day 5, i.e. 2 days after the injection of the
oligomers. In the absence of antisense treatment, the cyto-
plasm/nuclear volume ratio of the newly formed myotubes
begins normally to rise on days 3–4 [13,16], and the
formation of new endplates on the fibers becomes apparent
on day 5 [13,34]. Of three different anti-sense oligos tested,
only the oligomer targeting the translational start site (anti-
start) exerted a clear dose-dependent effect on the desmin
expression. In contrast, the oligomers targeting the mRNA
cap site (anti-cap), a sequence stretching from nt 245–264
(A-245) of myoD, or a control oligomer (corresponding to a
random sequence of four nucleotides), when applied in
concentrations between 20 nM and 20 AM, caused a variable
or less striking effect (Fig. 3). The formation of new endplates
on the myotubes was inhibited similarly as the expression of
desmin. Only the effect of the highest concentration of anti-
start is shown in Fig. 4. Based on the above dose–response
relationship, 20 AM of this oligomer was chosen to inves-
tigate the effect on muscle regeneration.
3.4. The stability of antisense oligos in the regenerating
muscle
Since injected oligonucleotides are subject to rapid
degradation, we tested the stability of the antisense oligo-
deoxynucleotides in the muscle tissue (Fig. 5). The phos-
phorothioate version of anti-start and its corresponding
scrambled oligo were well detectable 1 h after injection,
and even after 4 and 24h trace amounts were left. Oligomers
containing the naturally occurring phosphodiester linkage
are more prone to biodegradation and disappeared from the
muscle after 24h (see last lanes on Fig 5). We have therefore
used phosphorothioate oligos in our further experiments.
3.5. myoD Antisense phosphorothio oligomer initially
suppressed the mRNA level of myoD but thereupon caused
a coordinated augmentation of the mRNA levels of myoD,
myf-5 and myogenin in regenerating muscle
We monitored the effect of the phosphorothioate–phos-
phate version of anti-start on the transcript levels of myo-
genic regulatory factor mRNAs and used thereby
glyceraldehyde-3-phosphate dehydrogenase transcripts as
an internal control. The level of myoD mRNA, measured
by RT-PCR with primers encompassing the translation start
site, was found to be decreased already 1 h after injecting
anti-start into the muscles, meanwhile the mRNA levels of
myf-5 and myogenin were unchanged (Fig. 6). Interestingly,
when we also tried to measure the level of the myoD
transcripts by amplifying a fragment stretching from nt
726–946, which corresponds to the central part of myoD’s
cDNA, no such decrease was observed after 1 h.
Four hours after anti-start oligo injection, the transcript
levels of myoD, myf-5 and myogenin were not different
from the control, but after 24h the levels of the three
myogenic regulatory factors were increased by 60–100%
above controls. The transcript levels of MRF4, skeletal actin
and the neonatal sarcoplasmic/endoplasmic reticulum Ca2+
ATPase pump did not differ significantly from the controls
Fig. 5. The stability of 210 5 M antistart and its scrambled control
oligomer in the regenerating muscle at various times after the injection. The
last lanes show phosphodiester antistart oligo with the random control. S—
phosphorothioate, O—phosphodiester.
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(24h after oligo treatment), and neither did the levels of the
inhibitors of DNA binding Id1 and Id3 (1, 4 and 24h after
oligo treatment, Fig. 6). It should however be remarked, as
shown above, that the levels of the myogenic regulatory
factors and of the Ids themselves (set at 100% in these
experiments) were upregulated during muscle regeneration
compared to the uninjured muscle (Fig. 1B,C). It is interest-
ing to note that after 24h in the control-oligo-treated
regenerating muscles myoD and SERCA1b were also upre-
gulated. The former probably resulted from the repeated
injection of the regenerating muscle and was found to be
lower than in the antisense-treated muscles. The latter,
Fig. 6. mRNA levels of regenerating soleus muscles at different times after the injection of 2 10 5 M antistart phosphorothioate oligonucleotides on the third
day of regeneration. The 100% is set to the mean mRNA values of 3 days + 1 h regenerated non-antisense treated soleus muscle. White columns show values
from antisense treated and black columns from control oligo treated muscles. Note that the PCR analysis of fragment 726–946 of the myoD cDNAwas done
only on samples obtained at 1 h after oligo injection. The levels of MRF4, SERCA1b and a-actin were measured only at 24 h after the oligomer injection.
N= 3. Symbols as on Fig. 1. * indicates a significant difference to the control oligo treated muscle and # indicates a significant difference in the control oligo
treated muscles compared to the non-antisense treated ones.
E. Za´dor et al. / Biochimica et Biophysica Acta 1590 (2002) 52–63 59
reflecting the sudden uprise of this neonatal calcium pump
on days 3–5 of regeneration, did however not differ from
what was seen in antisense-treated counterparts. We also
must note here that the effect of the phosphorothioate–
phosphate oligos (antistart and control) was not distinguish-
able from that of the phosphate ester oligos on the morphol-
ogy and markers of regeneration as shown on Fig 4.
3.6. Injection of the antistart oligo decreases the myoD
protein level in the regenerating soleus
Next we assessed the effect of injection of 200 Al of
2 10 5 M antistart phosphorothioate oligo on the protein
level of myoD in the total muscle and the nuclear extract.
One hour after administration of the oligo, the levels of
myoD protein were decreased (P < 0.05) in total muscle
(Fig. 7A) and even more lowered (P < 0.01) in the nuclear
fraction (Fig. 7B) compared to the control.
3.7. Antisense inhibition of myoD does not affect the
expression pattern of MyHC isoforms, but increases the
number of small fibers in regenerating soleus
After 4 weeks of regeneration, 98% of the fibers in the
regenerated soleus muscles treated with antistart and control
phosphorothioate oligo expressed the myosin heavy chain of
the type I (slow-oxidative) fibers (MyHC1), and 12% of the
fibers expressed the myosin heavy chain of the type IIA
(fast-oxidative) fibers (MyHC2a) as it is shown on Fig 8.
This situation is not different from what is seen in non-
treated regenerating muscles [16,14]. However, in the anti-
start-treated regenerated soleus muscles 41F 2.1% of the
fibers showed areas under 2000 Am2, compared to only
16.5F 2.1% in the controls (N = 3, P < 0.05). The average
fiber areas, 3080 and 3350 Am2, subsequently, were not
significantly different from each other. Therefore, the anti
myoD treatment resulted in more small immature fibers
suggesting a delayed and incomplete regeneration as is also
observed in dystrophic muscles [18].
4. Discussion
A new finding of our work is that inhibition of myoD does
not immediately upregulate myf-5 or the other myogenic
regulatory factors although it delays regeneration. Myf-5 is
known to be increased in myogenic cells cultured from
myoD / mice [4,6] or in myoblast cell lines expressing
myoD antisense from a vector [35]. To our knowledge, our
experiments demonstrated for the first time that in the
regenerating muscle the temporal decrease in myoD is not
directly coupled to the increase of myf-5 mRNA, a marker of
quiescent adult skeletal muscle satellite cells [36]. This
suggests that the upregulation of myf-5 is more dependent
on extra cellular signals and developmental decisions than on
the selective downregulation of myoD. A single injection of
a mixed backbone phosphorothioate–phosphate diester anti-
sense oligo directed against the translational start codon of
myoD decreased this factor’s transcript and protein levels
already after 1 h. The inhibition depended on the stability of
the oligo that we have documented in this study and on the
turnover of myoD. Such a fast decrease of the myoD level
under inhibition is not unexpected in view of the high
turnover rate of myoD mRNA and protein in myogenic cells
Fig. 7. Inhibition of myoD level by the antistart phosphorothioate oligomer.
(A) Total extract and (B) the nuclear extract of the antistart-treated muscle.
The samples were collected on the third day of regeneration and 1 h after
the injection of oligos. The loadings were normalized to muscle weight and
protein content. The insert shows the immunoblots. N = 3. Symbols as in
Fig 1.
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[24,37]. The mechanism of this antisense inhibition probably
includes heteroduplex formation between the antisense oligo
and the targeted mRNA sequence. In the cytoplasm such an
RNA/DNA heterodimer cannot be translated, moreover
within the nucleus, it might act as a substrate of RNase H
and be removed by degradation [8].
Separate PCR amplifications of different fragments of the
myoD cDNA corresponding either to the targeted zone
comprising the translational start site or to a non-targeted
central part of the myoD cDNA showed that the antisense
treatment preferentially destroyed the region complementary
to the antisense probe. This is consistent with the suggestion
that the effect of the antistart oligo might not only involve
blocking of the translation but may also result from RNase
degradation of the targeted sequence. The fact that the
antistart oligo contained a TCCC sequence might have
improved its efficiency. Indeed, 48% of the most effective
antisense oligonucleotides contain such a sequence [20].
This motif, which was suggested to activate RNase was
found to be the most effective when present in introns,
thereby suggesting that the antisense action took place
inside the nucleus at the level of the primary gene transcript.
However, in our experiments this TCCC motif was clearly
exonic.
The antisense oligo was almost totally destroyed in the
regenerating muscle 4 h after its injection. The fact that the
myoD mRNA level was back to normal at this time
appeared to confirm this observation. To our surprise,
however, we found that 24h after administration of the
oligo, the mRNA levels of myoD were higher in the
antisense-treated muscles than in the controls. This appa-
rently compensatory augmentation of myoD transcript was
paralleled by a simultaneous increase of myf-5 and myoge-
nin mRNA levels. It is known that the mRNA levels of the
myogenic regulatory factors in soleus muscle are moder-
ately increased by denervation [38], which is not necessarily
followed by a corresponding increase in their protein levels
[39] and that the mRNAs are again decreased when rein-
nervation takes place in the regenerating muscles [13, 34].
Therefore it cannot be ruled out that the retarded onset of
regeneration and reinnervation in our experiments is also a
consequence of the compensatory mechanisms marked by
the secondary augmentation of myoD, myf-5 and myogenin
mRNAs rather than of the decrease of myoD itself.
The coordinated uprise of myoD, myf-5 and myogenin
transcript levels can be explained by the mutual positive
feedback MRFs exert on their gene transcription [40] rather
than by an increased number of muscle precursor cells, since
Fig. 8. The expression of myosin heavy chain proteins in the antistart thiooligo injected regenerating muscles after 28 days of regeneration. MyHC1 staining of
(a) scrambled control and (c) antistart treated muscle, MyHC2a staining of (b) scrambled control and (d) antistart-treated regenerated muscle. The arrows point
to the corresponding fibers on the parallel sections. Note arrow head on (d) indicating a small fiber.
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the mRNA levels of MRF4, Id1, Id3, skeletal actin and
SERCA1b were not elevated compared to the control. Such
a close coregulation of myoD, myf-5 and myogenin mRNAs
is also observed in vitro in many individual satellite cells in
culture [41] and in regenerating muscle [13]. Further, it has
been reported that increases in the stability of myoD mRNA
also result in a parallel elevation of myoD and myogenin in
C2 myoblasts [24].
The incorporation of BrdU showed that the first wave of
mitosis took place on the third day of regeneration. The
slightly earlier uprise of myoD levels therefore coincided
with the G1 phase [1], immediately preceding the S-phase
during which BrdU is incorporated. It is unlikely that before
the third day of regeneration, many satellite cells have been
activated into myogenic precursor cells and started to
proliferate. The myoD protein level was low in the normal
soleus, it began to rise already 1 day after injection and
became significantly higher on day 3 (Fig. 2A). MRF
production at that early time is most likely largely accounted
for by myogenic precursor cells immigrating into the
damaged muscle [42,43].
The observation that the levels of desmin did not decrease
during the first 3 days of regeneration was at variance with
the report of Ref. [44] which described a reduced level of this
intermediate filament protein after notexin injection. This
discrepancy must be explained by the different way in which
the muscle necrosis was induced in both groups. Whereas
Vater et al. [44] injected the venom subcutaneously, we
injected it intramuscularly. As shown in several earlier
reports of our group [12–14], necrosis elicited by intra-
muscular injection of notexin is complete. The increase in
the levels of desmin before the first mitotic wave on the third
day of regeneration may result either from activated satellite
cells or from muscle precursor cells that migrated from the
surrounding muscles into the injured soleus [42].
The precise timing of changes in the myogenic markers
such as the myogenic factors [13], the incorporation of
BrdU, the expression of desmin, the formation of myotubes
and reinnervation enabled us to monitor the progress of
muscle regeneration. The antisense treatment showed that
the expression of myoD orchestrates muscle reconstruction.
Even a relatively short-lasting inhibition of myoD expres-
sion was sufficient to disarrange the regenerative events with
long-lasting consequences, as shown by the elevated num-
bers of small fibers [18] remaining 4 weeks after antisense
injection. This disturbed regeneration was probably not only
caused by delaying the activation of satellite cells and
postponing the exit from the cell cycle [1], but also prevent-
ing myoblast fusion [5,7], a feature showed by myoD /
myoblasts. It is know that myoD controls the expression of
M-cadherin, which is required for cell cycle withdrawal and
myoblast fusion (reviewed in Ref. [43]). The temporal
decrease in the level of myoD elicited by myoD antisense
injection in regenerating muscle did not result in a signifi-
cant paralell upregulation of the level of myf-5 as reported to
be the case in primary myogenic cell culture [4], in satellite
cells of single fiber cultures [6] and in the developing
muscles of myoD knockout mice [2]. Also at variance with
our results is the observation that when myogenic cells were
transfected with a vector expressing myoD antisense
mRNA, the myf-5 mRNA was upregulated [35]. Therefore
our work suggests that short lasting inhibition of myoD
expression via antisense oligo injection exerts an effect
different from that obtained by myoD gene ablation or by
myoD antisense RNA transcribed from a transfected vector.
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